FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039123 [Registered on: 04/01/2022] Trial Registered Prospectively
Last Modified On: 13/12/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Trial of tDCS as Early Augmentation in Adults with Depression 
Scientific Title of Study   Randomised Controlled Single Blind Trial of Transcranial Direct Current Stimulation (tDCS) as Early Augmentation in Major Depressive Disorder  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Babli Kumari 
Designation  Junior Resident 
Affiliation  King Georges Medical University, Lucknow 
Address  Department of Psychiatry King George’s Medical University, Lucknow

Lucknow
UTTAR PRADESH
226003
India 
Phone  8603342638  
Fax    
Email  bablikumari.bk@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sujit Kumar Kar 
Designation  Additional Professor 
Affiliation  King Georges Medical University, Lucknow 
Address  Department of Psychiatry King George’s Medical University, Lucknow

Lucknow
UTTAR PRADESH
226003
India 
Phone  9956273747  
Fax    
Email  drsujita@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Babli Kumari 
Designation  Junior Resident 
Affiliation  King Georges Medical University, Lucknow 
Address  Department of Psychiatry King George’s Medical University, Lucknow

Lucknow
UTTAR PRADESH
226003
India 
Phone  08603342638  
Fax    
Email  bablikumari.bk@gmail.com  
 
Source of Monetary or Material Support  
King Georges Medical University, Shah Mina Road, Chowk, Lucknow, Uttar Pradesh 226003 
 
Primary Sponsor  
Name  King Georges Medical University Lucknow 
Address  Department of Psychiatry, King Georges Medical University, Shah Mina Road, Chowk Lucknow- 226003 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Babli Kumari  King Georges Medical University, Lucknow  Department of Psychiatry, King Georges Medical University, Lucknow
Lucknow
UTTAR PRADESH 
8603342638

bablikumari.bk@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, King Georges Medical University, UP  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F321||Major depressive disorder, singleepisode, moderate, (2) ICD-10 Condition: F322||Major depressive disorder, singleepisode, severe without psychotic features, (3) ICD-10 Condition: F331||Major depressive disorder, recurrent, moderate, (4) ICD-10 Condition: F332||Major depressive disorder, recurrent severe without psychotic features,  
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Intervention  Active Transcranial Direct Current Stimulation (tDCS)  A total of 10 sessions (on a daily basis) of tDCS will be delivered over a period of two weeks following a uniform treatment protocol as described below. TOI (Target of Interest): Right DLPFC: Cathode placement, Left DLPFC: Anode placement Strength of electric current : 2 mA Duration of therapy: 20 minutes/session Sessions: 10 over a period of 2 weeks RAMP time: 20 seconds along with medications  
Comparator Agent  Sham Transcranial Direct Current Stimulation (tDCS)  A total of 10 sessions (on a daily basis) of tDCS will be delivered over a period of two weeks following a uniform treatment protocol as described below. TOI (Target of Interest): Right DLPFC: Cathode placement, Left DLPFC: Anode placement Strength of electric current : 0.1 mA Duration of therapy: 20 minutes/session Sessions: 10 over a period of 2 weeks RAMP time: 20 seconds along with medications  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Age 18-60 years
2. Patients diagnosed with Major Depressive Disorder according to DSM-5
3. Willing to give Informed consent to participate in the study.
4. Drug Naive (at least drug free for the past 1 month) 
 
ExclusionCriteria 
Details  1. Patients with Treatment Resistant Depression.
2. Patients having Psychotic Depression.
Suicidal Patients
3. HAM-D (Hamilton Depression Rating Scale) less than 13
4. Medical co-morbidities that need immediate attention.
5. Any contraindications to tDCS.
6. Patients with any other co-morbid psychiatric disorder except Tobacco use disorders. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To study efficacy of transcranial direct current stimulation in Major Depressive Disorder  Assessment at 0, 2 and 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To study safety of transcranial direct current stimulation in Major Depressive Disorder  Assessment at each session 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   10/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Major Depressive Disorder (MDD) has the highest lifetime prevalence among various psychiatric disorders. It leads to poor quality of life and impaired role functioning. Many pharmacological (antidepressants) and non-pharmacological modalities (cognitive behavioural therapy) are used for the management. Despite adequate treatment, 20-30% of patients could not achieve remission. Various augmentation strategies are then used. Neuromodulation strategies repetitive transcranial magnetic stimulation (rTMS), and transcranial direct current stimulation (tDCS) have been implicated in refractory cases. 

tDCS has been found to be effective in managing depressive symptoms in various RCTs but its role as an early augmentation strategy has not been studied much. It is a relatively novel non-pharmacological intervention that has significant advantages over other Brain Stimulation Techniques in terms of portability, cost-effectiveness and safety. 

This study aims to determine the efficacy & safety of Transcranial Direct Current Stimulation (tDCS) as early augmentation in Drug Naive Patients with Major Depressive Disorder.” 

Procedure:

Patients will be recruited from the Adult Psychiatry Outpatient Services and Emergency Services, King George Medical University, Lucknow, Uttar Pradesh, India. Patients fulfilling the selection criteria will be enrolled and written informed consent will be taken. On the day of enrollment, Hamilton- Depression Rating Scale (HAM-D) and Beck’s Depression Inventory (BDI) will be a applied to assess severity of depressive symptoms and  Hamilton- Anxiety Rating Scale (HAM-A) for anxiety symptoms. tDCS side effects check-list will be applied to monitor the side-effects. Patients will be randomly allocated to two groups (Active and Sham tDCS) by random table method. Both groups of patients will be blind to the therapy procedure and prescribed uniform antidepressant medications. tDCS will be delivered as per the protocol. A total of 10 sessions will be given within 2 weeks and assessments will be done at baseline, week 2 and week 4 of the enrollment. 

Result:

After data collection, statistical analysis will be done using a computerised statistical program, Statistical Package for Social Sciences (SPSS). Mean change in rating scales will be compared after each assessment as well as between the two groups.  

 
Close